ResMed (RMD) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 20.4%. For ResMed, the consensus EPS estimate for the current year has increased 2.8% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy). Looking more specifically, Mind Medicine (MindMed) Inc. belongs to the Medical - Biomedical and Genetics industry, which includes 505 individual stocks and currently sits at #91 in the Zacks Industry ...